| (210) | Number of the EPO application | 16815196 |
| (220) | Filing date of the EPO application | 2016.06.22 |
| (80) | EPO patent specification publication (B) | EPB nr. 29/2021, 2021.07.21 |
| (110) | EPO patent number | 3310386 |
| (21) | Number of the application | e 2018 0432 |
| (71) | Name(s) of applicant(s), code of the country | JANSSEN BIOTECH INC., US; |
| (72) | Name(s) of inventor(s), code of the country | DOSHI Parul, US;
LOKHORST Henk M., NL;
MUTIS Tuna, NL; |
| (73) | Name(s) of owner(s), code of the country | JANSSEN BIOTECH INC., US; |
| (54) | Title of the invention | COMBINATION THERAPIES FOR HEME MALIGNANCIES WITH ANTI-CD38 ANTIBODIES AND SURVIVIN INHIBITORS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 39/395 (2006.01.01); A61P 35/00 (2006.01.01); C07K 16/18 (2006.01.01); C07K 16/28 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2018.06.30 |
| (30) | Priority | 201562182699 P, 2015.06.22, US; 201662319036 P, 2016.04.06, US |
| (86) | International application | PCT/US2016/038702, 2016.06.22 |
| (87) | International publication | WO 2016/209921, 2016.12.29 |